Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 May 19;14(5):e239099.
doi: 10.1136/bcr-2020-239099.

Azathioprine hypersensitivity syndrome: report of two cases

Affiliations
Case Reports

Azathioprine hypersensitivity syndrome: report of two cases

Tahlia McKenzie et al. BMJ Case Rep. .

Abstract

Azathioprine hypersensitivity syndrome is a rare but potentially severe side effect of azathioprine use. It has a variable and non-specific presentation making it difficult to distinguish from sepsis or disease relapse. High clinical suspicion is therefore required for recognition and prompt cessation of azathioprine for symptom resolution. Herewith two cases of severe azathioprine hypersensitivity syndrome are described, one in association with Sweet syndrome. Both presented with vague symptoms 2 weeks after commencing azathioprine for antineutrophil cytoplasmic antibody vasculitis. The differentials of sepsis and disease relapse were considered prior to cessation of azathioprine which resulted in a dramatic improvement in both cases. These cases highlight the diagnostic challenge azathioprine hypersensitivity syndrome presents. It should be suspected when there is a temporal relationship to drug initiation, with absence of infection or serological evidence of disease relapse.

Keywords: renal system; unwanted effects / adverse reactions.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

References

    1. Aleissa M, Nicol P, Godeau M, et al. . Azathioprine hypersensitivity syndrome: two cases of febrile neutrophilic dermatosis induced by azathioprine. Case Rep Dermatol;9:6–11. 10.1159/000454876 - DOI - PMC - PubMed
    1. Bidinger JJ, Sky K, Battafarano DF, et al. . The cutaneous and systemic manifestations of azathioprine hypersensitivity syndrome. J Am Acad Dermatol 2011;65:184–91. 10.1016/j.jaad.2010.04.041 - DOI - PubMed
    1. Sweet Syndrome - NORD (National Organization for Rare Disorders), 2019. Available: https://rarediseases.org/rare-diseases/sweet-syndrome/
    1. Acute febrile neutrophilic dermatosis | DermNet NZ, 2019. Available: https://www.dermnetnz.org/topics/acute-febrile-neutrophilic-dermatosis/
    1. Boomsma MM, Stegeman CA, van der Leij MJ, et al. . Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study. Arthritis Rheum 2000;43:2025–33. 10.1002/1529-0131(200009)43:9<2025::AID-ANR13>3.0.CO;2-O - DOI - PubMed

Publication types

MeSH terms

Substances